A Role of Vaginal DHA on Uterine Contractions in Patients at Low Risk for Preterm Birth

Inositol and human reproduction. From cellular metabolism to clinical use.
4 agosto 2017
A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy
4 agosto 2017

A Role of Vaginal DHA on Uterine Contractions in Patients at Low Risk for Preterm Birth

Summary

Preterm labor is a over the counter antibiotics public health problem and to this day, it’s the great challenge of modern obstetrics. We conducted a randomized double-blind controlled study. At the admission, all patients were submitted to cardiotocography. Patients with regular contractions but without decreasing of cervical length or funneling at transvaginal sonography were admitted. 90 patients at 24-34 weeks of gestation were finally recruited. Patients were randomly divided in two groups: A group (45 patients) received a modalertsingle transvaginal dose of docosahexaenoic acid (1 gr of DHA); B group (45 patients) received placebo. At 120 minutes, cardiotocographic examination was performed in all patients. A group showed a significant decrease in number and intensity of contractions (p <0,05 ) as compared to group B.

The results of our study show that vaginally administered www.yourcanadianmeds.com/product/phentermine/ DHA during pregnancy is effective on uterine contractions providing a significant decrease of spontaneous contractions and probably reducing the risk of preterm delivery.

Keywords: Preterm delivery; Singleton pregnancies; Uterine contraction; Vaginal DHA